Shandong Jincheng Pharmaceutical Group Co., Ltd, together with its subsidiaries, researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers active pharmaceutical ingredients, biopharmaceuticals, medical intermediates, fine chemicals, finished dosages, and pharmaceutical products. It also provides animal nutrition and health care, as well as CMO and CDMO services. The company was founded in 2004 and is based in Zibo, China.
Stock data | 2024 | Change |
---|---|---|
Price | $1.53 | N/A |
Market Cap | $585.51M | N/A |
Shares Outstanding | 383.88M | N/A |
Employees | 3.96K | N/A |